Related Experiment Video
Updated: Jun 24, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
Exosome-based anticancer vaccines: From Bench to bedside.
Guo Zhao1, Yuning Wang1, Shujun Xing1
1Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Cancer Letters
|June 2, 2024
Summary
Exosomes, tiny cell-derived vesicles, are promising for cancer immunotherapy and drug delivery due to their unique properties. This review explores exosome-based cancer vaccines and their clinical potential.
Area of Science:
- Cell Biology
- Immunology
- Biotechnology
Background:
- Exosomes are key mediators of intercellular communication, transferring molecules like DNA, RNA, and proteins.
- Their non-toxic, low-immunogenic, and stable nature makes exosomes ideal for drug development.
- Tumor and immune cell-derived exosomes have distinct compositions crucial for anticancer immunotherapy.
Purpose of the Study:
- To summarize exosome biogenesis, structure, composition, and functions.
- To describe the role of exosomes in cancer biology and tumor immunity.
- To review exosome-based anticancer vaccine development and clinical translation.
Main Methods:
- Literature review of exosome biology and function.
- Analysis of exosome roles in cancer immunity.
- Categorization and review of exosome-based anticancer vaccine strategies.
Main Results:
- Exosomes facilitate intercellular communication and molecule transfer.
- Exosomes play significant roles in tumor immunity and immune regulation.
- Three main types of exosome-based anticancer vaccines have been developed.
Conclusions:
- Exosome-based immunotherapy shares therapeutic goals with cancer vaccines.
- Challenges remain for the clinical application of exosome-based therapies.
- Further research into clinical translation and trials is essential for exosome-based anticancer vaccines.
Related Concept Videos
01:30Cancer Vaccines
354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K